Saad Z. Usmani, MD, FACP, Levine Cancer Institute
Advertisement
Articles by Saad Z. Usmani, MD, FACP, Levine Cancer Institute
Advertisement
Latest Updated Articles
Updates in Multiple Myeloma in the Frontline SettingPublished: January 29th 2021 | Updated:
Updates in Relapsed/Refractory MyelomaPublished: January 29th 2021 | Updated:
Third and Subsequent Line Options for Multiple MyelomaPublished: January 29th 2021 | Updated:
Rapid Readouts: Update of CARTITUDE-1Published: June 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5